|
GriseofulvinDrug - Griseofulvin The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL
Active Ingredient(s) -
Griseofulvin, Microcrystalline
Strength -
125MG/5ML
Applicant -
STIEFEL
New Drug Application (NDA) Number -
065200
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Mar 2, 2005
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Stiefel Laboratories Inc
Griseofulvin
Raxar Eq 200mg Base Tablet; Oral
Raxar Eq 400mg Base Tablet; Oral Raxar Eq 600mg Base Tablet; Oral Grisactin 125mg Capsule; Oral Grisactin 250mg Capsule; Oral Grifulvin V 125mg/5ml Suspension; Oral Grifulvin V 125mg/5ml Suspension; Oral Griseofulvin 125mg/5ml Suspension; Oral Kytril Eq 1mg Base Tablet; Oral Kytril Eq 2mg Base Tablet; Oral NewDrugInformation |